Trial
NCT07123493
Engineered T-Cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Haifeng Qin
Collaborators
—
Condition
Recurrent or Metastatic Solid Tumors With Positive ALPP
Intervention
Anti ALPP CAR-T cells treatment
Why stopped
Strategic Portfolio Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-28